Editor's Pick Spotlight
While Latinos make up 20% of the U.S. total population, they are facing higher rates of obesity and related conditions in which they are still struggling to get treated for. GLP-1 medications can reduce those statistics, yet accessing them remain limited by cost and coverage gaps.